Germany
Japan
United Kingdom
China
CD19 mouse monoclonal antibody, clone 4G7, Biotin
| Applications | FC |
| Reactivities | Human |
| Conjugation | Biotin |
Research Areas
Download
CD19 mouse monoclonal antibody, clone 4G7, FITC
| Applications | FC |
| Reactivities | Human |
| Conjugation | FITC |
CD19 mouse monoclonal antibody, clone 4G7, PerCP
| Applications | FC |
| Reactivities | Human |
| Conjugation | PerCP |
CD19 mouse monoclonal antibody, clone 4G7, PE-DL594
| Applications | FC |
| Reactivities | Human |
| Conjugation | PE-DL594 |
CD34 mouse monoclonal antibody, clone QBEnd-10, FITC
| Applications | FC |
| Reactivities | Human, Primate |
| Conjugation | FITC |
CD34 mouse monoclonal antibody, clone QBEnd-10, PE
| Applications | FC |
| Reactivities | Human, Primate |
| Conjugation | PE |
IL6 mouse monoclonal antibody, clone 6D7, Purified
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
IL6 mouse monoclonal antibody, clone 9D8, Purified
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 280.00
2 Weeks
IL2 Receptor alpha (IL2RA) mouse monoclonal antibody, clone B-B10, Biotin
| Applications | FC |
| Reactivities | Human |
| Conjugation | Biotin |
USD 300.00
2 Weeks
IL2 Receptor alpha (IL2RA) mouse monoclonal antibody, clone B-B10, PE
| Applications | FC |
| Reactivities | Human |
| Conjugation | PE |
USD 280.00
2 Weeks
IL2 Receptor alpha (IL2RA) mouse monoclonal antibody, clone B-F2, FITC
| Applications | FC |
| Reactivities | Human |
| Conjugation | FITC |
USD 270.00
2 Weeks
IL2 Receptor alpha (IL2RA) mouse monoclonal antibody, clone B-G3, Azide Free
| Applications | FC |
| Reactivities | Human |
CD10 (MME) mouse monoclonal antibody, clone B-E3, PE
| Applications | FC |
| Reactivities | Human |
| Conjugation | PE |
CD45 (PTPRC) (CD45RA) mouse monoclonal antibody, clone B-C15, FITC
| Applications | FC |
| Reactivities | Human |
| Conjugation | FITC |
CD45 (PTPRC) (CD45RA) mouse monoclonal antibody, clone B-C15, PE
| Applications | FC |
| Reactivities | Human |
| Conjugation | PE |
CD19 mouse monoclonal antibody, clone B-C3, Azide Free
| Applications | FC |
| Reactivities | Human |
CD19 mouse monoclonal antibody, clone B-C3, Biotin
| Applications | FC |
| Reactivities | Human |
| Conjugation | Biotin |
CD19 mouse monoclonal antibody, clone B-C3, FITC
| Applications | FC |
| Reactivities | Human |
| Conjugation | FITC |
CD19 mouse monoclonal antibody, clone B-C3, Purified
| Applications | FC |
| Reactivities | Human |
CD19 mouse monoclonal antibody, clone B-D3, PE
| Applications | FC |
| Reactivities | Human |
| Conjugation | PE |
CD34 Class I mouse monoclonal antibody, clone B-G25, Purified
| Applications | FC |
| Reactivities | Human |
CD34 Class I mouse monoclonal antibody, clone B-C34, Azide Free
| Applications | FC |
| Reactivities | Human |
CD34 Class I mouse monoclonal antibody, clone B-C34, FITC
| Applications | FC |
| Reactivities | Human |
| Conjugation | FITC |
CD34 Class I mouse monoclonal antibody, clone B-C34, Purified
| Applications | FC |
| Reactivities | Human |
CD34 Class I mouse monoclonal antibody, clone B-C34, PE
| Applications | FC |
| Reactivities | Human |
| Conjugation | PE |
CD34 Class III mouse monoclonal antibody, clone B-F23, PE
| Applications | FC |
| Reactivities | Human |
| Conjugation | PE |
CD34 Class III mouse monoclonal antibody, clone B-K34, PE
| Applications | FC |
| Reactivities | Human |
| Conjugation | PE |
c Kit (KIT) mouse monoclonal antibody, clone B-K15, Biotin
| Applications | FC |
| Reactivities | Human |
| Conjugation | Biotin |
c Kit (KIT) mouse monoclonal antibody, clone B-K15, Purified
| Applications | FC |
| Reactivities | Human |
CD130 (IL6ST) mouse monoclonal antibody, clone B-R3, FITC
| Applications | FC |
| Reactivities | Human |
| Conjugation | FITC |
CD130 (IL6ST) mouse monoclonal antibody, clone B-R3, Purified
| Applications | FC |
| Reactivities | Human |
IL6 mouse monoclonal antibody, clone B-E8, PE
| Applications | FC |
| Reactivities | Human |
| Conjugation | PE |
CD56 (NCAM1) mouse monoclonal antibody, clone NKI-nbl-1, Ascites
| Applications | IHC |
| Reactivities | Human |
CD7 mouse monoclonal antibody, clone MRQ-12, Supernatant
| Applications | IHC |
| Reactivities | Human |
CD21 (CR2) mouse monoclonal antibody, clone 2G9, Supernatant
| Applications | IHC |
| Reactivities | Human |
USD 430.00
2 Weeks
IL2 Receptor alpha (IL2RA) mouse monoclonal antibody, clone CD25-3G10, FITC
| Reactivities | Human |
| Conjugation | FITC |
USD 490.00
2 Weeks
IL2 Receptor alpha (IL2RA) mouse monoclonal antibody, clone CD25-3G10, PE
| Reactivities | Human |
| Conjugation | PE |
c Kit (KIT) mouse monoclonal antibody, clone C117/370, Purified
| Applications | IHC |
| Reactivities | Human |
CD19 mouse monoclonal antibody, clone HD37, FITC
| Applications | FC |
| Reactivities | Human |
| Conjugation | FITC |
CD19 mouse monoclonal antibody, clone HD37, PerCP
| Applications | FC |
| Reactivities | Human |
| Conjugation | PerCP |
CD19 mouse monoclonal antibody, clone HD37, PE
| Applications | FC |
| Reactivities | Human |
| Conjugation | PE |
IL1RA (IL1RN) mouse monoclonal antibody, clone 1384.92, Purified
| Applications | ELISA |
| Reactivities | Human |
TLR10 mouse monoclonal antibody, clone 9F4
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
TSLP mouse monoclonal antibody, clone 214E4.01
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
CD21 (CR2) mouse monoclonal antibody, clone 1F8, Supernatant
| Applications | IHC |
| Reactivities | Human |
CD21 (CR2) mouse monoclonal antibody, clone 1F8, Supernatant
| Applications | IHC |
| Reactivities | Human |
CD68 mouse monoclonal antibody, clone PG-M1, Supernatant
| Applications | IHC |
| Reactivities | Human |
Active filters
Category
- Antibodies
Antibody Hosts
- Mouse
Filter by
Target Symbol
- IL6 (130)
- CD4 (120)
- PECAM1 (109)
- IL1RL1 (102)
- PTPRC (88)
- CD99 (84)
- PDCD1 (84)
- CD19 (77)
- LGALS3 (77)
- KIT (71)
- CD68 (70)
- CD5 (65)
- MS4A1 (63)
- CD34 (61)
- NCAM1 (59)
- TNFRSF8 (51)
- CR2 (45)
- WNT3 (45)
- CD2 (39)
- MME (38)
- ESR1 (37)
- FCER2 (36)
- TYRO3 (36)
- CD22 (35)
- CRP (35)
- DVL2 (35)
- IL1RN (35)
- MAPK8 (34)
- CD274 (33)
- ANAPC11 (31)
- CD8A (31)
- ANAPC2 (30)
- ROR2 (30)
- CD33 (29)
- CD14 (28)
- CD79B (28)
- IL2RA (26)
- MAPK9 (26)
- CSF3 (23)
- IL3RA (22)
- ANPEP (19)
- TNF (19)
- CD3E (18)
- FCGR1A (15)
- MAPK10 (15)
- PTK7 (15)
- RORA (15)
- POSTN (14)
- CD74 (12)
- ITGB3 (12)
- CD79A (11)
- IL2 (11)
- IL6R (11)
- CD7 (10)
- IL36G (10)
- AGTPBP1 (9)
- IL12B (8)
- IL1A (8)
- IL6ST (8)
- ROR1 (8)
- FCGR3A (7)
- TLR8 (7)
- CD1A (5)
- ESR2 (5)
- HLA-DRB5 (5)
- ITGA2B (5)
- LEF1 (5)
- TOLLIP (5)
- CALR (4)
- CD163 (4)
- IL1B (4)
- IL36A (4)
- CRYGD (3)
- CXCL8 (3)
- HLA-A (3)
- IL6RA (3)
- WNT3A (3)
- CD46 (2)
- FUT4 (2)
- HLA-DQA2 (2)
- HLA-G (2)
- IL18 (2)
- ITGAX (2)
- TLR3 (2)
- TMED1 (2)
- ANAPC5 (1)
- ARAF (1)
- BRAF (1)
- CASP1 (1)
- CD10 (1)
- CD207 (1)
- CD30 (1)
- CDC42SE2 (1)
- CKMT2 (1)
- ELK3 (1)
- HLA CLASS II (1)
- IL10 (1)
- IL1R1 (1)
- IL1R2 (1)
- IRS1 (1)
Reactivities
Applications
Isotypes
Clonalities
Conjugates
Carrier-free
Knockout (KO) Validation
Modifications
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Druggable Genome (2194)
- Transmembrane (1734)
- ES Cell Differentiation/IPS (802)
- Secreted Protein (614)
- Adult stem cells (310)
- Protein Kinase (250)
- Embryonic stem cells (157)
- Stem cell - Pluripotency (118)
- Induced pluripotent stem cells (116)
- Phosphatase (87)
- Transcription Factors (84)
- Cancer stem cells (63)
- Protease (63)
- Nuclear Hormone Receptor (56)
- Stem cell relevant signaling - Wnt Signaling pathway (4)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
Pathways
- Hematopoietic cell lineage (1024)
- Cell adhesion molecules (CAMs) (740)
- T cell receptor signaling pathway (389)
- Cytokine-cytokine receptor interaction (383)
- Pathways in cancer (374)
- Primary immunodeficiency (330)
- Toll-like receptor signaling pathway (286)
- Jak-STAT signaling pathway (235)
- NOD-like receptor signaling pathway (230)
- Prion diseases (199)
- Leukocyte transendothelial migration (196)
- B cell receptor signaling pathway (194)
- Graft-versus-host disease (179)
- Antigen processing and presentation (170)
- Wnt signaling pathway (166)
- Melanogenesis (160)
- Hypertrophic cardiomyopathy (HCM) (159)
- Progesterone-mediated oocyte maturation (142)
- MAPK signaling pathway (141)
- Cytosolic DNA-sensing pathway (135)
- Colorectal cancer (119)
- Fc gamma R-mediated phagocytosis (110)
- RIG-I-like receptor signaling pathway (105)
- Endocytosis (99)
- Fc epsilon RI signaling pathway (97)
- Focal adhesion (96)
- Adipocytokine signaling pathway (94)
- Type II diabetes mellitus (94)
- Basal cell carcinoma (89)
- ErbB signaling pathway (85)
- Neurotrophin signaling pathway (83)
- Insulin signaling pathway (82)
- Acute myeloid leukemia (81)
- Epithelial cell signaling in Helicobacter pylori infection (81)
- GnRH signaling pathway (80)
- Pancreatic cancer (79)
- Lysosome (69)
- Oocyte meiosis (63)
- Cell cycle (62)
- Ubiquitin mediated proteolysis (62)
- Type I diabetes mellitus (58)
- Alzheimer's disease (55)
- Renin-angiotensin system (53)
- Regulation of actin cytoskeleton (52)
- Apoptosis (51)
- Hedgehog signaling pathway (49)
- Allograft rejection (47)
- Complement and coagulation cascades (46)
- Systemic lupus erythematosus (45)
- Notch signaling pathway (35)
- Natural killer cell mediated cytotoxicity (33)
- Pathogenic Escherichia coli infection (32)
- Dilated cardiomyopathy (30)
- Asthma (24)
- Autoimmune thyroid disease (23)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (19)
- Metabolic pathways (19)
- Amyotrophic lateral sclerosis (ALS) (18)
- Glutathione metabolism (18)
- TGF-beta signaling pathway (17)
- ECM-receptor interaction (13)
- Viral myocarditis (13)
- Chemokine signaling pathway (10)
- Endometrial cancer (10)
- Prostate cancer (10)
- Adherens junction (8)
- Thyroid cancer (7)
- Bladder cancer (6)
- Chronic myeloid leukemia (6)
- Glioma (6)
- Renal cell carcinoma (6)
- Non-small cell lung cancer (5)
- VEGF signaling pathway (5)
- Vascular smooth muscle contraction (5)
- Long-term potentiation (4)
- Melanoma (4)
- mTOR signaling pathway (4)
- Axon guidance (3)
- Gap junction (3)
- Long-term depression (3)
- Small cell lung cancer (3)
- Tight junction (3)
- Arginine and proline metabolism (1)
- Dorso-ventral axis formation (1)
- Inositol phosphate metabolism (1)
- Phosphatidylinositol signaling system (1)
- Vibrio cholerae infection (1)